Entegris, Inc. (ENTG) Upgraded to Buy at Dougherty & Company

Entegris, Inc. (ENTG) has been upgraded today by the securities research analysts at investment firm Dougherty & Company which raised Entegris from a “neutral” rating to “buy.”  Dougherty also increased their performance outlook for ENTG and adjusted its price target from $10.50 to $11.25 dollars.  Dougherty increased their rating and price target after Entegris earnings were reported and notes they are duly impressed by the performance of execution at the company which they say delivers strong cash flow and leverage.

ENTG has performed well throughout 2011 trading despite a major draw-down yesterday amid earnings as investors attempted to position themselves behind shares of ENTG.  ENTG would break below the 200-day simple moving average, only to close well-above it as traders began throwing themselves behind shares of the company back north.  In fact, within the span of 48 hours, shares have risen about $1.50 dollars from beneath widely regarded moving averages, to above.

Entegris, Inc. is slated to release their next earnings report on October 20th, 2011, and the current consensus EPS estimate is expected to be 23 cents.  Entegris last earnings report was released yesterday on July 21st, 2011, and announced EPS of 24cents with revenue totaling $209.2 million which was up 24.8% year to year.  ENTG is currently trading above its 50 & 200-day moving averages and 2011 is an up year for the company.

Entegris is a worldwide developer, manufacturer and supplier of products and materials used in processing and manufacturing in the semiconductor and other high-technology industries.  The company has market capitalization of $1,258,831,390 and 134,347,000 shares outstanding.  ENTG has a 52-week high of $10.58 with the low being $3.75 dollars.

Latest News

FleetCor Technologies  Earns “Hold” Rating from Mizuho
FleetCor Technologies Earns “Hold” Rating from Mizuho
Morningstar, Inc.  Insider Joseph D. Mansueto Sells 16,547 Shares of Stock
Morningstar, Inc. Insider Joseph D. Mansueto Sells 16,547 Shares of Stock
Analysts’ Weekly Ratings Changes for Alder Biopharmaceuticals
Analysts’ Weekly Ratings Changes for Alder Biopharmaceuticals
Gold Bits Coin Market Capitalization Tops $21.60 Million
Gold Bits Coin Market Capitalization Tops $21.60 Million
FlorinCoin  Market Cap Reaches $7.63 Million
FlorinCoin Market Cap Reaches $7.63 Million
Enrique A. Conterno Sells 25,000 Shares of Eli Lilly And Co  Stock
Enrique A. Conterno Sells 25,000 Shares of Eli Lilly And Co Stock


© 2006-2019 Ticker Report